535 top medical experts on Bullous Pemphigoid across 38 countries and 30 U.S. states, including 400 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.
- Bullous Pemphigoid: A chronic and relatively benign subepidermal blistering disease usually of the elderly and without histopathologic acantholysis.
- Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
- Broader Categories (#Experts): Autoimmune Diseases (3,976), Vesiculobullous Skin Diseases (3,611).
- Clinical Trials
: at least 60 including 2 Active, 22 Completed, 14 Recruiting
- Synonyms: Pemphigoid
- Zillikens, DetlefCenter for Research on Inflammation of the Skin CRIS, University of Lübeck, Lübeck, Germany; Department of Dermatology, Allergology, and Venereology, University of Lübeck, Lübeck, Germany, University of Lübeck, Lübeck, Germany.Subjects: Pemphigoid, Bullous; Autoantibodies; Pemphigus; Laminin; Autoantigens; Epidermolysis Bullosa AcquisitaCategories: Immunology; Diagnosis; Blood; Metabolism; Administration & Dosage; Drug Therapy
- Fairley, Janet A DermatologyDepartment of Dermatology, University of Iowa, Iowa City. Top HospitalRelevant US NIH Grant Funding: $438,790 over the last 5 yearsMedical school: University of Michigan Medical School (MD, 1981)Medicare AcceptedSubjects: Pemphigoid, Bullous; Autoantibodies; Immunoglobulin E; Eosinophils; Antibodies, Anti-Idiotypic; Antibodies, MonoclonalCategories: Immunology; Therapeutic Use; Metabolism; Physiology; Drug Therapy; Epidemiology
- Schmidt, EnnoLübeck Institute of Experimental Dermatology LIED, University of Lübeck, Lübeck, Germany; Department of Dermatology, Allergology and Venerology, University of Lübeck, Lübeck, Germany. Electronic address: .Subjects: Pemphigoid, Bullous; Autoantibodies; Pemphigus; Autoantigens; Skin; Epidermolysis Bullosa AcquisitaCategories: Immunology; Diagnosis; Blood; Therapeutic Use; Metabolism; Drug Therapy
- Payne, Aimee S DermatologyDepartment of Dermatology, the University of Pennsylvania, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. Top HospitalMedical school: Washington University School of Medicine (MD, 2001)Medicare Accepted; Medicare MIPS (Merit-based Incentive Payment System) rating: 78/100Disclosed payments from biomedical company (Janssen Research & Development, LLC) in 2021 for $3,100Subjects: Pemphigoid, Bullous; Pemphigus; Pemphigoid, Benign Mucous Membrane; Rituximab; Antibodies, Monoclonal; Antibodies, Monoclonal, HumanizedCategories: Epidemiology; Adverse Effects; Immunology; Administration & Dosage; Chemically Induced; Diagnosis
- Hall, Russell P DermatologyDepartment of Dermatology, Duke University Medical Center, Durham, North Carolina, USA. Top HospitalPhysician Highly CitedDisclosed payments from biomedical company (Almirall LLC) in 2021 for $650Subjects: Pemphigoid, Bullous; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Autoantibodies; Autoantigens; B-Cell Activating FactorCategories: Therapeutic Use; Chemistry; Drug Therapy; Blood; Cytology; Diagnosis
- Stanley, John R DermatologyDepartment of Dermatology, University of Pennsylvania, Philadelphia, PA, U.S.A. Top HospitalPhysicianSubjects: Pemphigoid, Bullous; Autoantibodies; Pemphigus; Autoantigens; Complement Activation; Complement C5aCategories: Immunology; Metabolism; Pathology; Blood; Diagnosis; Drug Effects
- Wieland, Carilyn N DermatologyDepartment of Dermatology, Mayo Clinic, Rochester, MN, USA. Top HospitalMedical school: University of Chicago, Pritzker School of Medicine (MD, 2005)Medicare Accepted; Medicare MIPS (Merit-based Incentive Payment System) rating: 82/100Subjects: Pemphigoid, Bullous; Autoantigens; Non-Fibrillar Collagens; Autoantibodies; Alzheimer Disease; Asymptomatic DiseasesCategories: Immunology; Blood; Epidemiology; Analysis; Pathology; Complications
- Feldman, Ron J DermatologyDepartment of Dermatology, Emory University School of Medicine, Atlanta, GA, USA. Top HospitalPhysicianRelevant US NIH Grant Funding: $609,523 over the last 5 yearsDisclosed payments in 2021 from 4 biomedical companies, totalling $6,200, including $3,100 from Janssen Research & Development, LLCSubjects: Pemphigoid, Bullous; Antibodies, Monoclonal; Exudates and Transudates; Leukotriene B4; Pemphigus; PruritusCategories: Complications; Pathology; Therapeutic Use; Blood; Cytology; Diagnosis
- Grando, Sergei A DermatologyDepartment of Dermatology, University of California Irvine, Irvine, CA, USA.Disclosed payments from biomedical company (GENZYME CORPORATION) in 2021 for $300Subjects: Pemphigoid, Bullous; Pemphigus; Consensus; Dermatology; Ficusin; Genetic Predisposition to DiseaseCategories: Complications; Genetics; Adverse Effects; Therapy; Immunology; Physiopathology
- Werth, Victoria P DermatologyDepartment of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania. Top HospitalPhysicianDisclosed payments in 2021 from 43 biomedical companies, totalling $77,882.33, including $15,191.5 from ABBVIE INC.Subjects: Pemphigoid, Bullous; Pemphigus; Dermatomyositis; Lupus Erythematosus, Cutaneous; Dermatology; FatigueCategories: Complications; Epidemiology; Diagnosis; Methods; Therapy; Standards
- Woodley, David T DermatologyDepartment of Dermatology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. Top HospitalMedical school: University of Missouri, Columbia School of Medicine (MD, 1973)Medicare Accepted; Medicare MIPS (Merit-based Incentive Payment System) rating: 77/100Subjects: Pemphigoid, Bullous; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal, Humanized; Anti-Allergic Agents; Dermatologic Agents; DermatologyCategories: Therapeutic Use; Drug Therapy; Adverse Effects; Chemically Induced; Diagnosis; Standards
- Zone, John J DermatologyImmunodermatology Laboratory, Department of Dermatology, University of Utah, UT, USA. Top HospitalPhysicianMedical school: University of Utah School of Medicine (MD, 1996)Medicare Accepted; Medicare MIPS (Merit-based Incentive Payment System) rating: 100/100Subjects: Pemphigoid, Bullous; Autoantibodies; Celiac Disease; Dermatology; Outcome Assessment, Health Care; Pemphigoid GestationisCategories: Blood; Diagnosis; Methods; Standards
- Culton, Donna A DermatologyDepartment of Dermatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. Top HospitalDisclosed payments in 2021 from 3 biomedical companies, totalling $1,800, including $1,800 from Grifols, S.A.Subjects: Pemphigoid, Bullous; Autoantibodies; Autoantigens; Biological Factors; Dermatology; EosinophilsCategories: Immunology; Therapeutic Use; Therapy; Diagnosis; Etiology; Physiology
- Diaz, Luis A DermatologyDepartment of Dermatology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA. Top HospitalDisclosed payments from biomedical company (Janssen Research & Development, LLC) in 2021 for $3,100Subjects: Pemphigoid, Bullous; Autoantigens; Mast Cells; Non-Fibrillar Collagens; Autoantibodies; DermatologyCategories: Immunology; Metabolism; Enzymology; Etiology; Therapy; Diagnosis
- Sinha, Animesh A DermatologyDepartment of Dermatology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, United States.Physician Case ReportsMedical school: Other (MD, 1982)Medicare Accepted; Medicare MIPS (Merit-based Incentive Payment System) rating: 69.3/100Disclosed payments in 2021 from 3 biomedical companies, totalling $55.71, including $24.56 from Incyte CorporationSubjects: Pemphigoid, Bullous; Pemphigus; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Consensus; DermatologyCategories: Diagnosis; Drug Therapy; Immunology; Physiopathology; Adverse Effects; Etiology
- Nishie, WataruDepartment of Dermatology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.Subjects: Pemphigoid, Bullous; Autoantibodies; Autoantigens; Non-Fibrillar Collagens; Dipeptidyl-Peptidase IV Inhibitors; Immunoglobulin GCategories: Immunology; Adverse Effects; Metabolism; Drug Therapy; Chemically Induced; Blood
- Yancey, Kim B DermatologyDepartment of Dermatology, University of Texas Southwestern Medical Center in Dallas, Dallas, Texas, USA. Electronic address: . Top HospitalPhysicianMedical school: Medical College of Georgia School of Medicine (MD, 1978)Medicare AcceptedSubjects: Autoantigens; Non-Fibrillar Collagens; Pemphigoid, Bullous; Epitopes; Anti-Allergic Agents; Antibodies, Anti-IdiotypicCategories: Genetics; Immunology; Therapeutic Use; Drug Therapy
- Lehman, Julia S DermatologyDepartment of Dermatology, Mayo Clinic, Rochester, Minnesota; Division of Anatomic Pathology, Mayo Clinic, Rochester, Minnesota. Top HospitalPhysician Case ReportsSubjects: Pemphigoid, Bullous; Autoantigens; Non-Fibrillar Collagens; Autoantibodies; Cause of Death; Death CertificatesCategories: Immunology; Mortality; Analysis; Blood; Diagnosis; Pathology
These expert listings are
for individual use without a fee. Biotechs,
Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and
other organizations may use this only for quick evaluations (no downloads, screen scraping or using the data) to identify the top medical experts for recruiting, advisory panels, boards,
and consulting. Please contact
us for licensing, customized queries, feedback and questions.
Note:
- Only the top 20 experts are shown. You may filter your results or use the geolocation tabs. Contact us to purchase the entire list.